Verlin Janzen, MD, FAAFP DESCRIPTION: OBJECTIVES:

Similar documents
Daralyn Hassan, MS, MT(ASCP) April 3rd, 2014 CLIA

Thursday April 6, 2017 LD1

PROGRAM GUIDE - UNIVERSITY CLIA REGISTERED LABORATORIES COMPLIANCE COMMITTEE

POINT OF CARE TESTING MED Laboratory Branch Kim DeGroat, RMLS - Frankfurt Region Wilfred Lovelock, RMLS - Dakar Region

How to Improve the Laboratory Experience CLS and MLT Working Together

TESTIMONY OF THOMAS HAMILTON DIRECTOR SURVEY & CERTIFICATION GROUP CENTER FOR MEDICAID AND STATE OPERATIONS CENTERS FOR MEDICARE & MEDICAID SERVICES

C A L I F O R N I A L A B O R AT O RY P E R S O N N E L

Quality Assurance Program For Hospital Based Point of Care Testing. Presented by: Jeanne Mumford, MT(ASCP) Pathology Supervisor, QA Specialist

Internal Lab Inspections: Are You Inspection Ready? Presented by: Jeanne Mumford, MT(ASCP) Manager, Point of Care Testing, JHM

The CLIA regulations..

Catholic Health Initiatives

Tutorial: Basic California State Laboratory Law

Rapid Specimen Testing In the Medical Office (POCT)

Centers for Medicare and Medicaid Services (CMS) Survey and Certification Group (SCG) Mission:

CE Update [generalist compliance/regulation management/administration and training] COLA Accreditation An Educational Experience

COLA CATALOG WE GIVE YOU THE TOOLS TO SUCCEED RESOURCES FOR LABORATORY PERSONNEL EDUCATIONAL COURSES, PROGRAMS, AND MATERIALS

Karen W. Dyer MT(ASCP), DLM Director, Division of Laboratory Services Centers for Medicare & Medicaid Services CLIA

Subject: Quality Management for Origin date: 3/06 Point of Care and Waived Testing Reviewed: 2009 /2010 Revised: 2/2009

COMMISSION ON LABORATORY ACCREDITATION. Laboratory Accreditation Program TEAM LEADER ASSESSMENT OF DIRECTOR & QUALITY CHECKLIST

Policy Subject Index Number Section Subsection Category Contact Last Revised References Applicable To Detail MISSION STATEMENT: OVERVIEW:

PART I HAWAII HEALTH SYSTEMS CORPORATION STATE OF HAWAII Class Specification for the

A COLA White Paper: FEDERAL GOVERNMENT QUESTIONS QUALITY IN WAIVED TESTING.

CAP Most Frequent Deficiencies and How to Avoid Them. March 11, 2015

CLIA & Individualized Quality Control Plan (IQCP) Karen W. Dyer MT(ASCP), DLM Director (Acting) Division of Laboratory Services

CLIA & Individualized Quality Control Plan (IQCP) Judith Yost Director Division of Laboratory Services

Standards, Guidelines, and Regulations

Regulatory,Quality & Emergency Preparedness. MaryBeth Parache Director, Quality Affairs New York Blood Center

SUCCESSION PLANNING: FILLING A LABORATORY DIRECTOR S SHOES PART ONE

CAP Accreditation and Checklists Update. Lyn Wielgos, MT(ASCP) Checklist Editor, CAP Accreditation Programs


EDUCATIONAL COMMENTARY KEY COMPONENTS OF AN INDIVIDUALIZED QUALITY CONTROL PLAN

US ): [42CFR ]:

CLIA S NEW IQCP SEABB. March 19, Linda Sigg, MT(ASCP)SBB,CQA(ASQ) Staff Lead Assessor, Accreditation, AABB

TITLE: POINT OF CARE TESTING

Center for Medicaid and State Operations/Survey and Certification Group

Symposium for Clinical Laboratories May 30 June 2, 2018: Session Descriptions

Improving Your POC Program: An Upside Down Map. Sheila K. Coffman MT(ASCP)

CLINICAL LABORATORY IMPROVEMENT AMENDMENTS OF 1988: HOW TO ASSURE QUALITY LABORATORY SERVICES

Standards for Laboratory Accreditation

Point of Care Testing

Personnel. From RLM, COM, GEN and TLC Checklists

3/14/2016. The Joint Commission and IQCP. Objectives. Before Getting Started

Nestor A.Guerrero,BSMT,RMT,CLS,MT(ASCP) Major (Ret), US Army Medical Service Corps

THE REGIONAL EMERGENCY MEDICAL SERVICES COUNCIL OF NEW YORK CITY, INC.

Online Clinical Competency Checklist CLS 1000 Core Clinical Laboratory Skills

CHAPTER 38 REGULATORY GUIDELINES IN THE MEDICAL LABORATORY

CLIA s New IQCP Requirements Are in Effect, or Are They?: Implementing Laboratory Risk Management Now to Ensure Success

PERSONNEL REQUIREMENTS. March 9, 2018

5/8/2015. Individualized Quality Control Plans (IQCP) Changes to the CMS Quality Requirements. CLIA Quality Control Evolution of the Process

Individualized Quality Control Plan (IQCP) Frequently Asked Questions Date: May 5, 2015 (last updated 08/21/2017)

Scope of Service. Department Mission

Standards for Forensic Drug Testing Accreditation

Plan for Quality to Improve Patient Safety at the POC

CAP Forensic Drug Testing Accreditation Program Standards for Accreditation

CLIA Compliance and Laboratory Safety

Global Outreach Activity Menu

Quality Medical and Laboratory Practice in Cellular Therapy

Point of Care Testing. BOPCC May 31, 2011 Beatrice O Keefe, Chief Laboratory Field Services California Department of Public Health

CLIA Regulations Update 2015

MLT 215 CLINICAL PRACTICE COURSE OUTLINE. Pre requisites: MLT 112, 200, 207, 212 & 214

1). AB-2436 Clinical laboratory testing.( )

Laboratory Risk Assessment: IQCP and Beyond. Ron S. Quicho, MS Associate Project Director Standards and Survey Methods, Laboratory July 18, 2017

IQCP. Ensuring Your Laboratory s Compliance With Individualized Quality Control Plans. November/December 2016

Fulton County Medical Center. Position Description. Pathologist, Laboratory Manager, and Medical Technologist

Report accurate, timely laboratory results to clinical staff

CLINICAL CHEMISTRY. Phone: The department is staffed 24 hours a day.

Request for Information: Revisions to Personnel Regulations, Proficiency Testing

Learning Objectives. Individualized Quality Control Plans. Agenda. Another Way To Determine QC? Hooray!!!! What is QC?

STANDARDS Point-of-Care Testing

College of Physicians and Surgeons of Saskatchewan Laboratory Quality Assurance Program. Policy Manual Edition

Primary Ingredients. Primary Ingredients. Referrals. Positive cash-flow. Dedication & growth Give it some time and put effort into it

What s New and Improved for the Laboratory Program in 2013 April 23, 2013

HINDS COMMUNITY COLLEGE MEDICAL LABORATORY TECHNOLOGY PROGRAM STUDENT HANDBOOK

Laboratory Accreditation Manual Edition Editor: Francis E. Sharkey, MD, FCAP

THE VALUE OF CAP S Q-PROBES & Q-TRACKS

SPECIMEN REQUIREMENTS

insights COLA Updates Into MAY / JUNE 12 COLA s

A Review and Analysis of the Clinical Laboratory Improvement Amendment of 1988: Compliance Plans and Enforcement Policy

Annual Compliance Notice to Providers 2013

Quality Laboratory Practice and its Role in Patient Safety

AMERICAN BOARD OF HISTOCOMPATIBILITY AND IMMUNOGENETICS Laboratory Director. Content Outline

insights INTO Quality Control MAY/JUNE 2013 COLA S

6/28/2016. Questions? Workshop 6 CAP Inspection Preparation Thursday, June 23, 2016

Best Practices for Equipment Calibration and Analytical Controls in the Diagnostics Laboratory

POSITION DESCRIPTION

QC for the Future: Laboratory Issues POCT and POL concerns

IQCP January Is Coming Fast What Do I Do?!? Jean Ball Bold, MBA, MT(HHS), MLT(ASCP

Clinical Laboratory Science Courses

4. Program Regulations

Massachusetts General Hospital Point of Care Testing Program

SOP WP6-QUAL-04, Version 1.0, 23 February 2014 Page 1 of 8. SOP Title: Laboratory (GCLP) supervision visits

Performance of Point-of-Care Testing in Unaccredited Settings:

RHC COMPLIANCE AND REGULATIONS

NEW CERTIFICATE PROGRAM PROPOSAL. 1. Title: Clinical Training Certificate Program in Clinical Laboratory Science

ASSEMBLY BILL No. 940

Highmark Reimbursement Policy Bulletin

Point of Care Testing Clinical Practice Standard and Policy (LTR31449) Version: 2.01

Guide to Become a Licensed Commercial Ambulance Service in Maryland

College of American Pathologists 325 Waukegan Road, Northfield, Illinois Advancing Excellence

Accreditation Education Innovation ISO 9001:2008

Transcription:

LD1 Introduction to Laboratory Medicine and Regulations Verlin Janzen, MD, FAAFP Family Physician & Laboratory Director Hutchinson Clinic, Hutchinson, KS Clinical Assistant Professor, University of Kansas School of Medicine, Wichita, KS DESCRIPTION: This opening session for the lab director qualification track is designed for physicians, and will provide the novice laboratory director with an orientation to the medical laboratory. This is your starting point as you seek to qualify as a laboratory director of a moderate complexity lab. Dr. Janzen will discuss the language of the laboratory, acronyms, and terms used in office laboratories today. In addition, he will give an overview of the CLIA law and regulations that will allow the attendee to assimilate the subsequent session material into a coherent body of knowledge. OBJECTIVES: At the end of the session, participants will be able to: Demonstrate a general understanding of what the CLIA regulations entail, and how they affect the POL Differentiate between CLIA and COLA Understand some common laboratory lingo Plan for the upcoming courses in the lab director education qualification track, and summarize the importance of each topic in becoming a competent laboratory director CRI and COLA do not endorse, directly or indirectly, the presentations given at this conference or the products or services provided by the exhibiting vendors. Presentations are intended to be free of bias. The use of any particular product is for demonstration purposes only, and does not imply an endorsement of the product by the presenter or the sponsors of the symposium. 2015 CRI

Verlin K Janzen, MD, FAAFP Family Physician & Laboratory Director Hutchinson Clinic, PA Hutchinson, KS History CLIA, COLA CLIA update Regulatory Process overview Test complexity model Overview of CLIA regulation high level 8 Steps to Regulatory Compliance Laboratory Lingo common terms

C linical L aboratory I mprovement A ct/amendments 1967 - CLIA 67 - regulated Medicare, Medicaid, & interstate commerce testing 1987 Wall Street Journal reports by Walt Bogdanich Deadly Mistakes reported by Lea Thompson on WRC-TV in Washington, D.C. 1988 - CLIA 88 signed by President Reagan 1990 - Proposed Rules & Regulations issued 1992 - Final Rules & Regulations published 1993 Went into effect 1994 PT regulations went into effect 2003 Revised Final Rule published

Laboratory means a facility for the biological, microbiological, serological, chemical, immunohematological, hematological, biophysical, cytological, pathological, or other examination of materials derived from the human body for the purpose of providing information for the diagnosis, prevention, or treatment of any disease or impairment of, or the assessment of the health of, human beings. Facilities only collecting or preparing specimens (or both) or only serving as a mailing service and not performing testing are not considered laboratories. Laboratories testing for forensic purposes only Sites that test for research only and results not used for diagnosis, treatment or prognosis Laboratories in New York State and Washington These states enforce their own laboratory regulations Some states have requirements beyond CLIA

Law Regulations Interpretive Guidelines Law Passed by Congress Signed by President Regulations developed by Department (HHS) Approved by Secretary of Dept Interpretive Guidelines developed by Dept

Federal Register Proposed Comment Period Final Code of Federal Regulations (CFR) Interpretive Guidelines A General Provisions B Certificate of Waiver C Registration, PPM, CMS certificates D Accreditation Certificate F Fees H Proficiency Testing J Facility Requirements K Quality Systems M Personnel Q Inspection R - Enforcement Code of Federal Regulations 121 pages

291 page.pdf file http://www.cms.hhs.gov/clia/03_interpretive_guidelines_for_laboratories.asp CLIA Regulations Fed Reg, CFR Test Complexities CLIA Forms Survey Procedures Interpretive Guidelines State CLIA offices Links to CMS, FDA

Advises and recommends on technical and scientific aspects of CLIA Composed of laboratory scientists, physicians, laboratory industry representatives, consumer advocate Meets twice each year with representatives of CDC, FDA and CMS

Some states require laboratory to be licensed In some states this may be limited to reference and hospital laboratories Some states require laboratory personnel licensure Contact state CLIA office to determine requirements States may have communicable disease and hazardous waste requirements Laboratory is responsible for adherence Waived Moderate Complexity High Complexity

Waived simple tests, no harm if done incorrectly Moderate Complexity most tests PPM (Provider-performed microscopy) KOH/wet mount, microscopic UA (not gram stain) High Complexity a few more complex tests Microbiology Your lab requires a certificate from CMS to operate which certificate is determined by the most complex test you do. Each test is regulated by it s test complexity Personnel QC - etc

Certificate of Waiver -issued to labs performing only waived tests Certificate for PPMP-issued to labs where a physician, midlevel, or dentist performs only PPM procedures or waived tests Certificate of Registration - issued to a laboratory that enables the entity to conduct moderate or high complexity laboratory testing or both until the entity is determined by survey to be in compliance with the CLIA regulations Certificate of Compliance - is issued to a laboratory after an inspection that finds the laboratory to be in compliance with all applicable CLIA requirements Certificate of Accreditation - This is a certificate that is issued to a laboratory on the basis of the laboratory's accreditation by an accreditation organization approved by CMS 1. Dipstick Urinalysis 2. Fecal Occult Blood 3. Ovulation Tests - visual 4. Urine Pregnancy Tests - visual 5. Sed Rate, non-automated 6. Hemoglobin CuSO4 7. Hematocrit - spun 8. Blood Glucose w/ device approved for home use http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfclia/analyteswaived.cfm

100 + Analytes now waived Comprehensive Metab Profile Lipids total chol, HDL, trigs FSH, TSH, LH, urine hcg BNP A1c, microalbumin, fructosamine Ketones blood & urine Hb/Hct, platelet aggregation Cannabinoids, cocaine, benzodiazepines, ethanol, methamphetamines, morphine, opiates, propoxyphene, PCP, tricyclics Lyme disease H pylori antibodies Mono, influenza a/b, Grp A strep, RSV, adenovirus (eye) Trichomonas Protime Adenovirus (conj fluid) Bacterial vaginosis Ferning in saliva (ovulation) Lithium Male fertility (motile sperm > 10M) Syphilis (Dec 14) http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfclia/analyteswaived.cfm PROVIDER PERFORMED MICROSCOPY 1. Moderate complexity test 2. Uses microscope 3. Personally performed by a provider (MD/PA/NP) 4. Labile specimen 5. QC not available 6. Limited specimen handling or processing required

1. Direct wet mount preps (presence/absence of bacteria, fungi, parasites, and human cellular elements) 2. KOH preps 3. Pinworm examinations 4. Fern tests 5. Post-coital exams (direct, qualitative examinations of vaginal or cervical mucous) 6. Urine sediment examinations 7. Nasal smears for granulocytes 8. Fecal leukocyte examinations 9. Qualitative semen analysis (limited to the presence or absence of sperm and detection of motility) http://www.cms.gov/regulations-and-guidance/legislation/clia/downloads/ppmplist.pdf MODERATE HIGH Automated tests WBC diffs normal cells Microscopic UA Some automated dipstick UA Slide agglutination tests Most non-waived direct Ag tests (strep, etc) Urine colony count kits Strep culture presumptive ID Gram Stain (cervical, urethral) Cytology, histology, genetics Non-automated tests Radioimmunoassay WBC diffs abn cell ID Manual hematology / coag Bacteriology: isolation & ID Gram stains (most) Uncategorized tests Waived tests (if manuf instructions not followed) Searchable database: www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfclia/search.cfm

MODERATE Normal Cells Automated tests WBC diffs normal cells Microscopic UA Some automated dipstick UA Slide agglutination tests Most non-waived direct Ag tests (strep, etc) Urine colony count kits Strep culture presump ID Gram Stain (cervical, urethral) Usual WBC segs, bands lymphs, monos, eos, basos Viral Lymphs Toxic gran / vacuoles RBC Morphology micro/ macro, aniso, hypo, target, oval-ocytes NOT: premature forms, unusual forms POLICY: define for your lab

Waived Facility Quality Systems Personnel Proficiency Testing Routine Inspections Register follow manuf instructions allow unannounced surveys notify of changes in ownership/director/menu PPM Moderate High Brief Overview

Space, ventilation, utilities Minimize contamination Sufficient instrument/supplies for type & volume of testing Compliance with Federal, State, and local laboratory requirements OSHA, Hazmat, etc Safety (physical, chemical, biological, electrical, biohazard) Record retention guidelines Transfusion Service requirements Quality Control (QC) Calibration, preventive maintenance, test verification standards Proficiency Testing (PT) evaluation and corrective action Quality assessment (QA) Test ordering, recording & reporting requirements Specimen submission, handling, referral Reagent storage Complaints, communication

Personnel Category Lab Director Technical Consultant Technical Supervisor General Supervisor Test Complexity PPM Moderate High MD, DO, DPM, NP, PA -- MD/DO w/20hrs, PhD, MS, BS MD, DO, PhD, MS, BS -- -- Pathologist, experience, grandfathered -- Pathologist, MD, DO, PhD, MS, BS MD, DO, PhD, MS, BS Clinical Consultant MD, DO, PhD MD, DO, PhD Testing Personnel MD, DO, DPM, NP, PA Minimum req- HS Grad Minimum Req - AD w/science degree ONLY moderate & high complexity labs Every two years Announced depends Unannounced: CMS, Joint Commission, CAP Announced: COLA (2 wk), JC (5 d - very small labs) Can include observe testing, reporting, specimen collection interview employees access to all laboratory facilities access to all laboratory records/documents copy records for HHS inspectors test on-site PT samples

COMPLAINT FOLLOWUP of previous problems to determine COMPLIANCE with certificate requirements VALIDATION of accrediting agency inspections random unannounced additional $$$ for re-inspections or complaint inspections Waived Facility Quality Systems Personnel Proficiency Testing Routine Inspections Register follow manuf instructions allow unannounced surveys notify of changes in ownership/director/menu PPM Moderate High

1. Certificate Fee paid by all labs to CMS Lab Type # Spec Vol Fee Lab Type # Spec Vol Fee Waived NA Sched E NA 25-50K $650 PPM NA Sched F NA 50-75K $1,100 Low Vol A NA < 2000 $150 Sched G NA 75-100K $1,550 Sched A 3 2-10K $150 Sched H NA 100-500K $2,040 Sched B 4 2-10K $150 Sched I NA 0.5-1 M $6,220 Sched C 3 10-25K $430 Sched J NA > 1M $7,940 Sched D 4 10-25K $440 2. Compliance Fee paid to inspecting entity (State, COLA, CAP, JCAHO, AOA, etc) Kinder & Gentler CLIA Educational Focus Problems if intentional violations cheating on PT willful disregard of regulations immediate jeopardy PT failures (1 st time you fail 2/3) usually 2 nd chance

Principal Sanctions suspension, limitation, or revocation of certificate Intermediate/Alternative Sanctions directed plan of corrections COLA: Plan of Required Improvement (PRI) civil monetary penalties payment for costs on continuous or intermittent on-site monitoring and follow-up inspections suspension of Medicare/Medicaid payments Criminal Sanctions incarceration/fines for intentional violation of CLIA Alternative to CMS CMS labs - surveyed/inspected by State Private, non-profit COLA, Joint Commission, College of American Pathologists (CAP), AOA Requirements must be =/> CMS Validation surveys by CMS/state - 5% sample Fees Certificate fee - paid by all labs to CMS Compliance fee - by inspecting agency

Private, non-profit entity Physician directed: AAFP, ACP, AMA Educational, self-assessment driven Accredits Physician office labs, community hospital labs, mobile labs, VA & DOD facilities Mission COLA is a physician-directed organization whose purpose is to promote excellence in laboratory medicine and patient care through a program of voluntary education, consultation, and accreditation COLA CLIA

Cost Easier to understand criteria Phone assistance? POL friendly (does NOT mean easier) Educational approach Self-assessment

POL 49% Non- POL 51% NY-Wash Accred 1% 5% PPM 23% POL CMS 10% NY-Wash 5% Accred 8% PPM 6% Non-POL CMS 5% Waived 61% Waived 76%

See pages in notebook Lucia Berte Lab Medicine Quality Qorner Lingo Lessons Acronyms/Abbreviations pg Glossary of terms page Also on CD-ROM

Certificate of Waiver Piece of paper from CMS that allows you to operate a waived laboratory Centers for Medicare & Medicaid Services (CMS) Oversee program Centers for Disease Control and Prevention (CDC) Scientific expertise, CLIAC cmte Food & Drug Administration (FDA) Categorize tests

Quality Control (QC) Process of testing a specimen with an known value like a patient in order to assure methodology is working correctly before testing/reporting patient specimens Quality Assurance (QA) Process of evaluating lab operations retrospectively if problem found, correcting it then reassess. Process to improve operations. Standard Operating Procedure One method of writing laboratory procedures for use by laboratorians

Proficiency Testing (PT) A means of verifying accuracy of laboratory tests using an external testing company sometimes called external quality control. How it works You select PT provider & analytes Unknown samples are sent from a PT provider three times a year for analysis by the POL using the same methodology as patient samples. Results are then graded by the PT company Reports are sent to the lab and CMS/accreditor BS Degree Medical Technologist - MT(ASCP) Clinical Laboratory Scientist CLS(NCA) Medical Laboratory Scientist MLS(ASCP) (1) Associate Degree Medical Laboratory Technician MLT(ASCP) Clinical Laboratory Technician CLT(NCA) Medical Laboratory Technician MLT(ASCP) (1) Other Non-laboratorians Medical Assistant (MA), Certified Medical Assistant (CMA), RN/LPN, HS grads (1) Oct 2009 ASCP BOR & NCA merging to ASCP Board of Certification (8/09 G2 Reports)

Overview COW can only perform waived tests PPMP can perform waived and PPM tests Moderate complexity High complexity testing has more stringent personnel (testing and laboratory director) requirements than moderate complexity testing

MODERATE COMPLEXITY Laboratory Director Clinical Consultant Technical Consultant Testing Personnel HIGH COMPLEXITY Laboratory Director Clinical Consultant Technical Supervisor General Supervisor Testing Personnel **Qualified individual may hold more than one position Enroll every year for REGULATED analytes Perform split sample testing or enroll in PT for UNregulated analytes Evaluate performance, take corrective action, and follow up with quality assessment

Policies, processes and procedures covering all phases of the testing process General laboratory Pre-analytic systems Analytic systems Post-analytic systems Personnel trained in all policies, processes and procedures Including training on laboratory safety and blood borne pathogens Competency for all personnel on procedures they perform Document - maintenance of personnel records of education, training, competency

Accuracy Precision Reportable range Reference range For large instrumentation seek assistance of instrument vendor to accomplish Follow manufacturer s instructions for QC At a minimum two levels of control each day of testing Perform calibration and calibration verification of the reportable range as directed by the manufacturer

INCORPORATE QUALITY ASSESSMENT ACTIVITIES THROUGHOUT THE TESTING PROCESS QA essential for all pre-analytic, analytic and post-analytic processes Demonstrate corrective action as needed Follow up on the effectiveness of corrective action

Description % POL cited Proper storage of reagents & specimens 6.1% Twice annual QA check for analytes without PT 5.3% Analytic systems QA 2.8% Procedure manual contents 4.4% Test reports patient ID 4.3% Lab Director qualifications / job performance 4.0% Test systems lab determined performance specs 3.0% Employee competency P&P, performance 3.1% QA program 3.6% Calibration verification 2.9% https://www.cms.gov/regulations-and- Guidance/Legislation/CLIA/Downloads/CLIAtopten.pdf Description Competency assessments employees & consultants Lack of QC on waived tests when manuf requires Lack of PT review by LD & staff Calibration verification Lab Director QC & QA duties Transitional Citation EQC tests that will need IQCP Personnel records documentation of qualifications Calibration failure to perform/document QC materials failure to verify manuf ranges Lab Director PT duties % POL cited https://